🚨 $GCTK
As previously disclosed, on July 14, 2026, Glucotrack, Inc. entered into a securities purchase agreement as supplemented by a joinder dated August 4, 2026 , with certain investors pursuant to which the Company issued to the Bridge Investors senior secured convertible promissory notes and ...
As previously disclosed, on July 14, 2026, Glucotrack, Inc. entered into a securities purchase agreement as supplemented by a joinder dated August 4, 2026 , with certain investors pursuant to which the Company issued to the Bridge Investors senior secured convertible promissory notes and ...
SEC Filing: GCTK
Click to view the official SEC document.
www.sec.gov
September 28, 2026 at 9:29 PM
🚨 $GCTK
As previously disclosed, on July 14, 2026, Glucotrack, Inc. entered into a securities purchase agreement as supplemented by a joinder dated August 4, 2026 , with certain investors pursuant to which the Company issued to the Bridge Investors senior secured convertible promissory notes and ...
As previously disclosed, on July 14, 2026, Glucotrack, Inc. entered into a securities purchase agreement as supplemented by a joinder dated August 4, 2026 , with certain investors pursuant to which the Company issued to the Bridge Investors senior secured convertible promissory notes and ...
$CDT approved 1-for-25 reverse split to meet listing rules. Shares drop, core strategy and risks unchanged. $CDT $AIFF $JAGX $TVRD $GCTK $LONA $ONCO $NYXH $CYCN $SCNI
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 09/25/26
export-download.canva.com
September 25, 2026 at 8:30 PM
$CDT approved 1-for-25 reverse split to meet listing rules. Shares drop, core strategy and risks unchanged. $CDT $AIFF $JAGX $TVRD $GCTK $LONA $ONCO $NYXH $CYCN $SCNI
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
#GCTK Lōkahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™
https://www.stocktitan.net/news/GCTK/lokahi-therapeutics-tm-expands-ai2-pipeline-tm-program-through-s82dp69abh1r.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/GCTK/lokahi-therapeutics-tm-expands-ai2-pipeline-tm-program-through-s82dp69abh1r.html?utm_source=stocktitan-bluesky&utm_medium=social
Lōkahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 25, 2026 at 1:00 PM
#GCTK Lōkahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™
https://www.stocktitan.net/news/GCTK/lokahi-therapeutics-tm-expands-ai2-pipeline-tm-program-through-s82dp69abh1r.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/GCTK/lokahi-therapeutics-tm-expands-ai2-pipeline-tm-program-through-s82dp69abh1r.html?utm_source=stocktitan-bluesky&utm_medium=social
☀️ PREMARKET #$AKAM +18% on a REAL $11.6B Anthropic deal (CPUs, not GPUs). #$GCTK -12% after $3.1M offering at $2.04 — dilution kills spikes. #$INLF +113% on NO news = penny pump. #$APUS +25% on MindWave blockchain deal. #$MGLD +91% float squeeze. One legit mover; the rest is pure casino tape.
September 25, 2026 at 12:15 PM
🚀 GlukoTrack #$GCTK surged nearly $3/share after-hours, fueled in part by attention from the “Overdrive” chat group and positive biotech sentiment following successful live product demonstrations and scalp treatments. #trading #stockmarket #clinicaltrials
September 24, 2026 at 11:10 PM
🚀 GlukoTrack #$GCTK surged nearly $3/share after-hours, fueled in part by attention from the “Overdrive” chat group and positive biotech sentiment following successful live product demonstrations and scalp treatments. #trading #stockmarket #clinicaltrials
#DDAmanda caught $GCTK before it ran. Now up 109%. #DDAmanda Chart
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
September 24, 2026 at 10:33 PM
#DDAmanda caught $GCTK before it ran. Now up 109%. #DDAmanda Chart
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
Most searched small-cap stocks, Thurs Sept 24th - #$SMR #$CLSK #$PURR #$BTE #$FRMI #$AMC #$OPEN #$EOSE #$CYPH #$BENF #$GRML #$SKYQ #$APUS #$GCTK #$PFSA #$WRBY #$TRMD #$OUST #$ONDS #$GLND - More: crystalequityresearch.com/most-searche... - #smallcap
Most Searched, Thursday September 24, 2026 – Crystal Equity Research
crystalequityresearch.com
September 24, 2026 at 10:03 PM
🚨 $GCTK
On September 24, 2026, the Company issued a press release announcing the pricing of the Offering.
On September 24, 2026, the Company issued a press release announcing the pricing of the Offering.
SEC Filing: GCTK
Click to view the official SEC document.
www.sec.gov
September 24, 2026 at 9:16 PM
🚨 $GCTK
On September 24, 2026, the Company issued a press release announcing the pricing of the Offering.
On September 24, 2026, the Company issued a press release announcing the pricing of the Offering.
$PRME gets FDA IND OK for PM647 to treat alpha-1 antitrypsin deficiency, clearing path for US trials and advancing prime-editing drugs. $GCTK $JAGX $HCWB $VKTX $ACAD $SRZN $DNA $ARTL $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 09/24/26
export-download.canva.com
September 24, 2026 at 8:30 PM
$PRME gets FDA IND OK for PM647 to treat alpha-1 antitrypsin deficiency, clearing path for US trials and advancing prime-editing drugs. $GCTK $JAGX $HCWB $VKTX $ACAD $SRZN $DNA $ARTL $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
$GCTK ripping 28.6% up this session, 43,963,306 shares traded. Recent headlines point to Glucotrack Prices $3.1M Offering Of Stock At $2.04/Share. T… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-bk-up-tape&utm_term=research
September 24, 2026 at 2:13 PM
$GCTK ripping 28.6% up this session, 43,963,306 shares traded. Recent headlines point to Glucotrack Prices $3.1M Offering Of Stock At $2.04/Share. T… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-bk-up-tape&utm_term=research
$GCTK ripping 58.6% up so far this session, 38M shares traded, after Glucotrack priced a $3.1M offering of stock at $2.04/share. Tapeboard caught… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-bk-up-scanner&utm_term=scanner&s=GCTK
September 24, 2026 at 1:43 PM
$GCTK ripping 58.6% up so far this session, 38M shares traded, after Glucotrack priced a $3.1M offering of stock at $2.04/share. Tapeboard caught… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-bk-up-scanner&utm_term=scanner&s=GCTK
#DDAmanda caught $GCTK before it ran. Now up 109%. #DDAmanda Chart
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
September 24, 2026 at 12:50 PM
#DDAmanda caught $GCTK before it ran. Now up 109%. #DDAmanda Chart
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
Previous winners: $RKT $PLUG $SPCX
Find the next winner: https://DDAmanda.com
$GCTK ripping 17.7% premarket on 26.5m shares, gap open to $2.60 from $2.03 close. Recent headlines: Glucotrack Prices $3.1M Offering Of Stock At $2… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-tape&utm_term=scanner&s=GCTK
September 24, 2026 at 12:48 PM
$GCTK ripping 17.7% premarket on 26.5m shares, gap open to $2.60 from $2.03 close. Recent headlines: Glucotrack Prices $3.1M Offering Of Stock At $2… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-tape&utm_term=scanner&s=GCTK
#GCTK Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
https://www.stocktitan.net/news/GCTK/glucotrack-inc-announces-pricing-of-3-million-public-m4u9k77hisax.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/GCTK/glucotrack-inc-announces-pricing-of-3-million-public-m4u9k77hisax.html?utm_source=stocktitan-bluesky&utm_medium=social
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Glucotrack (GCTK) priced a public offering on September 24, 2026, expecting approximately $3.1 million in gross proceeds. The best-efforts offering includes 169,388 common shares at $2.04 per share and pre-funded warrants to purchase up to 1,350,220 shares at $2.039 per warrant. The warrants are being offered instead of common shares to certain investors. Gross proceeds are before placement agent fees and offering expenses.The offering was priced at-the-market under Nasdaq rules. Closing is expected on or about September 25, 2026, subject to customary conditions. Dawson James Securities is the sole placement agent. The offering uses a Form S-3 registration statement that became effective October 3, 2024.
www.stocktitan.net
September 24, 2026 at 12:45 PM
#GCTK Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
https://www.stocktitan.net/news/GCTK/glucotrack-inc-announces-pricing-of-3-million-public-m4u9k77hisax.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/GCTK/glucotrack-inc-announces-pricing-of-3-million-public-m4u9k77hisax.html?utm_source=stocktitan-bluesky&utm_medium=social
SELL $GCTK (GCTK.O) [StockDilution] @ 12:45:00Z
September 24, 2026 at 12:45 PM
SELL $GCTK (GCTK.O) [StockDilution] @ 12:45:00Z
#Trading #Stockmarket
Stock Premarket - Sep 24, 2026
See StockQuakes.substack.com
UP
↑ GCTK Glucotrack, Inc. 109.4%
↑ PFSA Profusa, Inc. 97.6%
↑ SRZN Surrozen, Inc. 66.0%
↑ YMAT J-Star Holding Co. 64.0%
↑ WETO Wetour Robotics LTD 50.3%
↑ TNMG Tnl Mediagene 28.6%
↑ NCPL Netcapital Inc. 27.4%
Stock Premarket - Sep 24, 2026
See StockQuakes.substack.com
UP
↑ GCTK Glucotrack, Inc. 109.4%
↑ PFSA Profusa, Inc. 97.6%
↑ SRZN Surrozen, Inc. 66.0%
↑ YMAT J-Star Holding Co. 64.0%
↑ WETO Wetour Robotics LTD 50.3%
↑ TNMG Tnl Mediagene 28.6%
↑ NCPL Netcapital Inc. 27.4%
StockQuakes | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with thousands of subscribers.
StockQuakes.substack.com
September 24, 2026 at 12:34 PM
#Trading #Stockmarket
Stock Premarket - Sep 24, 2026
See StockQuakes.substack.com
UP
↑ GCTK Glucotrack, Inc. 109.4%
↑ PFSA Profusa, Inc. 97.6%
↑ SRZN Surrozen, Inc. 66.0%
↑ YMAT J-Star Holding Co. 64.0%
↑ WETO Wetour Robotics LTD 50.3%
↑ TNMG Tnl Mediagene 28.6%
↑ NCPL Netcapital Inc. 27.4%
Stock Premarket - Sep 24, 2026
See StockQuakes.substack.com
UP
↑ GCTK Glucotrack, Inc. 109.4%
↑ PFSA Profusa, Inc. 97.6%
↑ SRZN Surrozen, Inc. 66.0%
↑ YMAT J-Star Holding Co. 64.0%
↑ WETO Wetour Robotics LTD 50.3%
↑ TNMG Tnl Mediagene 28.6%
↑ NCPL Netcapital Inc. 27.4%
📊 Premarket movers 9/24: #$GCTK still running (+112%) on its AI biotech deal 🔬. #$WETO #$DCX #$YMAT also spiking on thin float/news. Losers: #$BENF #$VSA #$ARTL down 20-31%, likely giving back recent pops. #$SFIX -19.5%, probably earnings-related — the one real mid-cap on this list. 👀 Classic micro-cap.
September 24, 2026 at 11:40 AM
📊 Premarket movers 9/24: #$GCTK still running (+112%) on its AI biotech deal 🔬. #$WETO #$DCX #$YMAT also spiking on thin float/news. Losers: #$BENF #$VSA #$ARTL down 20-31%, likely giving back recent pops. #$SFIX -19.5%, probably earnings-related — the one real mid-cap on this list. 👀 Classic micro-cap.
🧠 #$GCTK GlucoTrack spikes premarket (+114%!) after subsidiary Lokahi Therapeutics lands its first paid external deal — glioblastoma nonprofit Innovate GBM taps its AI asset-search platform 🔬. But: tiny $1.62M market cap, stock down ~97% over 12mo. Classic microcap news pop — extreme volatility,
September 24, 2026 at 11:24 AM
🧠 #$GCTK GlucoTrack spikes premarket (+114%!) after subsidiary Lokahi Therapeutics lands its first paid external deal — glioblastoma nonprofit Innovate GBM taps its AI asset-search platform 🔬. But: tiny $1.62M market cap, stock down ~97% over 12mo. Classic microcap news pop — extreme volatility,
$GCTK ripping 87.7% up premarket on 10,252,696 shares, these verticals can fade fast on the open. Tapeboard chart is up, scanner is tracking the move… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-gap&utm_term=research
September 24, 2026 at 10:22 AM
$GCTK ripping 87.7% up premarket on 10,252,696 shares, these verticals can fade fast on the open. Tapeboard chart is up, scanner is tracking the move… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-gap&utm_term=research
$gctk ripping 120.7% premarket on 8,522,936 shares. Tapeboard flagged $GCTK at $4.10 (4:08 am et, scan: top gainers). against current price, +10% sin… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-gap&utm_term=research
September 24, 2026 at 9:13 AM
$gctk ripping 120.7% premarket on 8,522,936 shares. Tapeboard flagged $GCTK at $4.10 (4:08 am et, scan: top gainers). against current price, +10% sin… https://tapeboard.com/go/bsky/research/GCTK?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=gctk-pm-up-gap&utm_term=research
Most searched small-cap stocks, Wed Sept 23rd - #$KEEL #$RXRX #$XNDU #$EOSE #$TE #$CYPH #$GLND #$IPDN #$IMCC #$ARTL #$DCOY #$GCTK #$WU #$LAC #$ICHR #$GRML #$JAGX #$GCTK #$ASH #$ALHC - More: crystalequityresearch.com/most-searche... - #smallcap
Most Searched, Wednesday September 23, 2026 – Crystal Equity Research
crystalequityresearch.com
September 23, 2026 at 10:25 PM
🚨 AH movers: #$GCTK +98%, #$NCPL +82% ripping on thin float; #$BENF -25%, #$NEOV -21% getting crushed. No confirmed catalysts yet — classic low-float gap noise. 🎯 Wait for the open, watch the 50% retrace zones, don't chase blind. Size small, confirm the news first. 慢慢買 🙏 #penny stocks
September 23, 2026 at 9:33 PM
$GCTK shifts capital to Lōkahi's asset acquisitions; Glucotrack stays on CGM, prioritizing LT-100 & expanding ai² for late-stage therapies. $ARTL $VTGN $BMEA $IMVT $JAGX $TLSA $CVKD $CGEM $SLXN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 09/23/26
export-download.canva.com
September 23, 2026 at 8:30 PM
$GCTK shifts capital to Lōkahi's asset acquisitions; Glucotrack stays on CGM, prioritizing LT-100 & expanding ai² for late-stage therapies. $ARTL $VTGN $BMEA $IMVT $JAGX $TLSA $CVKD $CGEM $SLXN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
$GCTK — M&A Communication
Glucotrack, Inc. (GCTK) issued a shareholder update on September 23, 2026, detailing the strategic direction of its Lōkahi Therapeutics subsidiary following the July 14 business combination.
🧵 continued ↓
Glucotrack, Inc. (GCTK) issued a shareholder update on September 23, 2026, detailing the strategic direction of its Lōkahi Therapeutics subsidiary following the July 14 business combination.
🧵 continued ↓
September 23, 2026 at 6:01 PM
$GCTK — M&A Communication
Glucotrack, Inc. (GCTK) issued a shareholder update on September 23, 2026, detailing the strategic direction of its Lōkahi Therapeutics subsidiary following the July 14 business combination.
🧵 continued ↓
Glucotrack, Inc. (GCTK) issued a shareholder update on September 23, 2026, detailing the strategic direction of its Lōkahi Therapeutics subsidiary following the July 14 business combination.
🧵 continued ↓